MedPath

A randomized controlled trial to verify the non-inferiority of partially covered self-expandable metal stent (PCSEMS) to uncovered self-expandable metal stent (UCSEMS) for biliary drainage during neoadjuvant therapy in pancreatic cancer patients with obstructive jaundice

Not Applicable
Recruiting
Conditions
pancreatic cancer
Registration Number
JPRN-UMIN000041737
Lead Sponsor
Hokkaido University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(1) history of biliary drainage with a metal stent; (2) history of chemotherapy/chemoradiotherapy for pancreatic cancer; (3) biliary obstruction that progresses to the hepatic hilum; (4) Eastern Cooperative Oncology Group Performance Status (ECOG-PS) 4; (5) history of gastrointestinal tract reconstruction except for Billroth I reconstruction; (6) the major duodenal papilla unreachable by a duodenal endoscope; (7) current pregnancy or suspected pregnancy; (8) unsuitable for inclusion at the discretion of the physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biliary event rate until surgery after biliary stenting with a metal stent
Secondary Outcome Measures
NameTimeMethod
(1) curative resection rate (2)Time to Recurrent biliary obstruction (3)Chemotherapy accomplishment/delay/discontinuation (4)Other stent-related adverse events (5)Frequency and severity of adverse events after curative surgery
© Copyright 2025. All Rights Reserved by MedPath